Samples of Popular Diabetes Drug Contain Potential Carcinogen, F.D.A. Says
Testing found nitrosamine contamination in some samples of Januvia, but regulators will allow Merck to continue selling the drug for now.
Source: NYT Health - Category: Consumer Health News Authors: Andrew Jacobs Tags: Drugs (Pharmaceuticals) Diabetes Regulation and Deregulation of Industry Shortages Cancer Food and Drug Administration Merck & Company Inc your-feed-healthcare Source Type: news
More News: Cancer | Cancer & Oncology | Diabetes | Endocrinology | Food and Drug Administration (FDA) | Health | Januvia | Merck